The SM Journey: Sharing
Explore insights and strategies for managing the disease long-term.
-
-
I’d rather be at home: On (not) leaving the house with SM
-
Advice for parenting with systemic mastocytosis
-
HT-KIT receives FDA Orphan Drug Designation for SM
-
FDA grants Breakthrough Designation to bezuclastinib for nonadvanced SM
-
My 2-year journey to getting disability for indolent SM
-
SM without skin involvement may mean higher anaphylaxis risk
